Literature DB >> 23753231

Cytomegalovirus pneumonia in hematopoietic stem cell recipients.

Giovanna Travi1, Steven A Pergam2.   

Abstract

Cytomegalovirus (CMV) is a frequently encountered infection following hematopoietic cell transplantation, and tissue invasive pneumonia is a dreaded complication of the virus in this population. In this review of CMV pneumonia, we address epidemiology, pathogenesis, diagnostics, current therapy, and strategies to prevent the development of CMV. We also review emerging treatment and prevention options for this challenging disease.
© The Author(s) 2013.

Entities:  

Keywords:  CMV pneumonia; antiviral; cytomegalovirus; hematopoietic cell transplant; prevention

Mesh：

Substances：

Year:  2013        PMID： 23753231      PMCID： PMC3775875          DOI： 10.1177/0885066613476454

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN： 0885-0666            Impact factor:   3.510


  154 in total

Review 1.  Pulmonary toxicities from targeted therapies: a review.

Authors:  Nicholas A Barber; Apar Kishor Ganti
Journal:  Target Oncol       Date:  2011-11-11       Impact factor: 4.493

2.  Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.

Authors:  Corinna La Rosa; Jeff Longmate; Simon F Lacey; Teodora Kaltcheva; Rahul Sharan; Denise Marsano; Peter Kwon; Jennifer Drake; Brenda Williams; Sharon Denison; Suenell Broyer; Larry Couture; Ryotaro Nakamura; Sanjeet Dadwal; Morris I Kelsey; Arthur M Krieg; Don J Diamond; John A Zaia
Journal:  J Infect Dis       Date:  2012-03-07       Impact factor: 5.226

Review 3.  The biology of cytomegalovirus drug resistance.

Authors:  Morgan Hakki; Sunwen Chou
Journal:  Curr Opin Infect Dis       Date:  2011-12       Impact factor: 4.915

4.  The novel anticytomegalovirus compound AIC246 (Letermovir) inhibits human cytomegalovirus replication through a specific antiviral mechanism that involves the viral terminase.

Authors:  Thomas Goldner; Guy Hewlett; Nicole Ettischer; Helga Ruebsamen-Schaeff; Holger Zimmermann; Peter Lischka
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 5.  An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.

Authors:  Angela Panoskaltsis-Mortari; Matthias Griese; David K Madtes; John A Belperio; Imad Y Haddad; Rodney J Folz; Kenneth R Cooke
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

6.  Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients.

Authors:  Filippo Milano; Steven A Pergam; Hu Xie; Wendy M Leisenring; Jonathan A Gutman; Ivy Riffkin; Victor Chow; Michael J Boeckh; Colleen Delaney
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

Review 7.  Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.

Authors:  Christian Renaud; Angela P Campbell
Journal:  Curr Opin Infect Dis       Date:  2011-08       Impact factor: 4.915

8.  Significance of herpesvirus 6 in BAL fluid of hematology patients with acute respiratory failure.

Authors:  E Mariotte; D Schnell; C Scieux; F Agbalika; J Legoff; P Ribaud; N Boissel; B Schlemmer; E Azoulay
Journal:  Infection       Date:  2011-05-03       Impact factor: 3.553

9.  The impact of early viral infections and graft-versus-host disease on immune reconstitution following paediatric stem cell transplantation.

Authors:  H Olkinuora; E von Willebrand; J M Kantele; O Vainio; K Talvensaari; U Saarinen-Pihkala; S Siitonen; K Vettenranta
Journal:  Scand J Immunol       Date:  2011-06       Impact factor: 3.487

10.  Generation of multivirus-specific T cells to prevent/treat viral infections after allogeneic hematopoietic stem cell transplant.

Authors:  Ulrike Gerdemann; Juan F Vera; Cliona M Rooney; Ann M Leen
Journal:  J Vis Exp       Date:  2011-05-27       Impact factor: 1.355
View more
  23 in total

Review 1.  Current Understanding of Cytomegalovirus Reactivation in Critical Illness.

Authors:  Hannah Imlay; Ajit P Limaye
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

2.  Coreactivation of Human Herpesvirus 6 and Cytomegalovirus Is Associated With Worse Clinical Outcome in Critically Ill Adults.

Authors:  Paula Lopez Roa; Joshua A Hill; Katharine A Kirby; Wendy M Leisenring; Meei-Li Huang; Tracy K Santo; Keith R Jerome; Michael Boeckh; Ajit P Limaye
Journal:  Crit Care Med       Date:  2015-07       Impact factor: 7.598

3.  ATS Core Curriculum 2016. Part IV. Adult Pulmonary Medicine Core Curriculum.

Authors:  Gaëtane C Michaud; Colleen L Channick; Anica C Law; Jessica B McCannon; MaryEllen Antkowiak; Garth Garrison; David Sayah; Richard H Huynh; Anna K Brady; Rosemary Adamson; Hilary DuBrock; Praveen Akuthota; Chad Marion; Charles Dela Cruz; James A Town; Başak Çoruh; Carey C Thomson
Journal:  Ann Am Thorac Soc       Date:  2016-07

4.  Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection.

Authors:  K Frenzel; J Lehmann; D H Krüger; L Martin-Parras; L Uharek; J Hofmann
Journal:  Med Microbiol Immunol       Date:  2013-12-15       Impact factor: 3.402

5.  Influence of sphingosine-1-phosphate signaling on HCMV replication in human embryonal lung fibroblasts.

Authors:  Anika Zilch; Christian Rien; Cynthia Weigel; Stefanie Huskobla; Brigitte Glück; Katrin Spengler; Andreas Sauerbrei; Regine Heller; Markus Gräler; Andreas Henke
Journal:  Med Microbiol Immunol       Date:  2018-04-26       Impact factor: 3.402

6.  Human embryonic lung fibroblasts treated with artesunate exhibit reduced rates of proliferation and human cytomegalovirus infection in vitro.

Authors:  Ai-Hong Zeng; Yang-Ying Ou; Ming-Ming Guo; Xuan Dai; De-Zhi Zhou; Rui Chen
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

7.  Detection of Cytomegalovirus in Bronchoalveolar Lavage Fluid from HIV-Positive Individuals with Community Acquired Pneumonia.

Authors:  Arati Mane; Pankaj Gujar; Shraddha Gaikwad; Tilak Dhamgaye; Arun Risbud
Journal:  J Clin Diagn Res       Date:  2017-07-01

8.  Risk Factors for Cytomegalovirus Reactivation and Association With Outcomes in Critically Ill Adults With Sepsis: A Pooled Analysis of Prospective Studies.

Authors:  Hannah Imlay; Sayan Dasgupta; Michael Boeckh; Renee D Stapleton; Gordon D Rubenfeld; Ying Chen; Ajit P Limaye
Journal:  J Infect Dis       Date:  2021-06-15       Impact factor: 5.226

Review 9.  Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation.

Authors:  Ren Lin; Qifa Liu
Journal:  J Hematol Oncol       Date:  2013-12-17       Impact factor: 17.388

10.  Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis.

Authors:  Susanna K Tan; Elizabeth B Burgener; Jesse J Waggoner; Kiran Gajurel; Sarah Gonzalez; Sharon F Chen; Benjamin A Pinsky
Journal:  Open Forum Infect Dis       Date:  2016-02-10       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.